AllRock Bio Inc.

About AllRock Bio Inc.

AllRock Bio is a biotechnology company dedicated to advancing impactful therapies for cardiopulmonary diseases, such as pulmonary hypertension and interstitial lung diseases. Their mission is to design and execute strategies that efficiently demonstrate the value of life-saving drugs, accelerating development through cutting-edge science, global partnerships, and comprehensive clinical trial planning to improve patients' lives worldwide.

Products & Services

ROC-101:An orally administered, potentially best-in-class pan-ROCK inhibitor being investigated for pulmonary arterial hypertension (PAH) and pulmonary hypertension with interstitial lung disease (PH-ILD).

Pulmonary Arterial Hypertension (PAH) Therapies:Novel therapies targeting PAH, a severe condition characterized by elevated blood pressure in the pulmonary arteries, affecting the lungs and the right side of the heart.

Specialties

Drug Development Cardiopulmonary Diseases Pulmonary Hypertension Interstitial Lung Diseases Fibrotic Conditions Clinical Trial Planning

Funding History

Debug: View Raw Funding Data

#	Type	Amount Fields	Date Fields	Investors
1	RT: Series A T: - FT: Series A	A: 50000000 MR: - FA: $50 million FAN: 50000000	D: 2025-09-16 FD: 2025-09-16	2 investors

Series A Latest

2025-09-16

$50.0M

2 investors (Pro only)

Growth Metrics

+45%

Employee Growth

YoY

3.2x

Funding Growth

Last Round

12

Markets

Operating

10K+

Customers

Active

View 3 more growth metrics with Pro

Unlock All Metrics

Mock Up

Team & Leadership

C

Catherine Pearce

CEO & Founder, AllRock Bio

J

Justin Thompson

CBO & Founder

B

Bill Marshall

CMO

J

Jack Greene

CTMO

A

Andrea Ledford

CFO

S

Serra Elliott

Sr. Director, Corporate Development

View 14 more team members with Pro

Unlock Full Team Directory

Recent News

AllRock Bio Inc. Announces New Product Launch

2 days ago

Company unveils innovative solution to transform the industry, expanding market reach and capabilities...

Leadership Team Expands with Industry Veteran

1 week ago

New executive brings 20+ years of experience to accelerate growth and strategic initiatives...

Company Recognized as Industry Leader

2 weeks ago

Receives prestigious award for innovation and customer satisfaction in competitive market...

Key Competitors

C1

Competitor Alpha

Series B · $50M raised

C2

Competitor Beta

Series C · $120M raised

C3

Competitor Gamma

Series A · $25M raised

C4

Competitor Delta

Seed · $10M raised